You just read:

New Five Year Data for STELARA®▼ (Ustekinumab) Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis

News provided by

Janssen

06 Jun, 2012, 08:00 BST